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Mapping global trends in vaccine confidence and 
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Summary
Background There is growing evidence of vaccine delays or refusals due to a lack of trust in the importance, safety, 
or effectiveness of vaccines, alongside persisting access issues. Although immunisation coverage is reported 
administratively across the world, no similarly robust monitoring system exists for vaccine confidence. In this study, 
vaccine confidence was mapped across 149 countries between 2015 and 2019.
Methods In this large-scale retrospective data-driven analysis, we examined global trends in vaccine confidence using 
data from 290 surveys done between September, 2015, and December, 2019, across 149 countries, and including 
284 381 individuals. We used a Bayesian multinomial logit Gaussian process model to produce estimates of public 
perceptions towards the safety, importance, and effectiveness of vaccines. Associations between vaccine uptake and a 
large range of putative drivers of uptake, including vaccine confidence, socioeconomic status, and sources of trust, 
were determined using univariate Bayesian logistic regressions. Gibbs sampling was used for Bayesian model 
inference, with 95% Bayesian highest posterior density intervals used to capture uncertainty.
Findings Between November, 2015, and December, 2019, we estimate that confidence in the importance, safety, 
and effectiveness of vaccines fell in Afghanistan, Indonesia, Pakistan, the Philippines, and South Korea. We found 
significant increases in respondents strongly disagreeing that vaccines are safe between 2015 and 2019 in 
six countries: Afghanistan, Azerbaijan, Indonesia, Nigeria, Pakistan, and Serbia. We find signs that confidence has 
improved between 2018 and 2019 in some EU member states, including Finland, France, Ireland, and Italy, with 
recent losses detected in Poland. Confidence in the importance of vaccines (rather than in their safety or 
effectiveness) had the strongest univariate association with vaccine uptake compared with other determinants 
considered. When a link was found between individuals’ religious beliefs and uptake, findings indicated that 
minority religious groups tended to have lower probabilities of uptake.
Interpretation To our knowledge, this is the largest study of global vaccine confidence to date, allowing for cross-
country comparisons and changes over time. Our findings highlight the importance of regular monitoring to detect 
emerging trends to prompt interventions to build and sustain vaccine confidence.
Funding European Commission, Wellcome, and Engineering and Physical Sciences Research Council.
Copyright © 2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 
license.
Introduction
Alongside persisting issues of access to health services, 
waning vaccine confidence has taken a toll on immu­
nisation programmes across the globe,1–4 contributing 
to stag nating or decreasing immunisation rates and 
consequent surges in vaccine­preventable diseases such 
as measles.5,6 In this context, WHO has named vaccine 
hesitancy as one of the top ten threats to global health in 
2019 alongside climate change.7
Founded in 2010, the Vaccine Confidence Project (VCP) 
was established to develop systematic approaches to 
monitoring public confidence in vaccines and to inform 
policy makers and stakeholders of the changing trends 
and determinants of vaccine confidence across the 
globe. Over the past decade, the VCP has compre­
hensively explored the landscape of confidence issues 
and experiences in managing confidence crises around 
the world.8–11 The VCP has conducted numerous surveys, 
focus groups, in­depth qualitative research, and large­
scale digital media analytics,12–14 as well as convened 
expert roundtables and workshops to understand context­
specific attitudes to vaccines among the general public,14,15 
health­care professionals and providers,15 and pregnant 
women.16 The VCP continues to research the roots, 
trends, and impacts of vaccine confidence issues at 
national and supranational levels to inform policy and 
trust­building activities and mitigate the need for crisis 
management in immunisation programmes.
Among a multiplicity of factors influencing vaccine 
decisions,17 key drivers of public confidence in vaccines 
were identified as trust in the importance, safety, and 
effectiveness of vaccines, along with compatibility of 
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vaccination with religious beliefs.18 These findings have 
resulted in the development of a Vaccine Confidence 
Index (VCI) survey tool (first implemented in 201514) to 
measure individual perceptions on the safety, impor­
tance, effectiveness, and religious compatibility of 
vaccines. The VCI questionnaire has the primary focus of 
measuring confidence across multiple countries while 
being minimal, thus allowing ready integration into 
existing global surveys. The VCI survey is one of a diverse 
set of metrics and indices used to measure confidence or 
hesitancy such as the Parent Attitudes About Childhood 
Vaccines Survey, which measures vaccine hesitancy 
among parents;19 the Vaccination Confidence Scale, 
which measures confidence in adolescent vaccination;20 
the 5­C scale (confidence, complacency, constraints, 
calcu lation, and collective responsibility), which iden­
tifies psychological barriers of vaccination behaviour;21 
and the SAGE Vaccine Hesitancy Scale, which has been 
deployed across multiple countries.22–26
In this large­scale retrospective study, we explore global 
trends in vaccine confidence between 2015 and 2019. We 
combine previously published data from nearly a quarter of 
a million individual survey responses with 50 000 add i­
tional interviews from 2019. To date, no comparable global 
estimates and monitoring of vaccine confidence are 
available, prohibiting a quantitative understanding of the 
relationship between vaccine coverage, socioeconomic 
demographics, and confidence. This ana lysis aims to 
provide multiyear global­level estimates of vaccine confi­
dence for 149 countries worldwide, exploring trends in 
confidence and the global determinants of uptake including 
socioeconomic determinants and sources of trust.
Methods
Data sources
Between September, 2015, and December, 2019, reported 
vaccine confidence levels were collected from 284 381 indi­
viduals aged 18 years or older across 149 countries as part 
of 290 nationally representative surveys. One country 
was surveyed over six different timepoints (Philippines), 
13 countries were surveyed over four timepoints, 28 over 
three timepoints, 40 over two timepoints, and 67 once. 
We grouped countries and territories by WHO regional 
classification. We classified the territories of Hong 
Kong, Northern Cyprus, and the occupied Palestinian 
territory into the Western Pacific, European, and Eastern 
Mediterranean regions, respectively.
Survey collection has been conducted through collabo­
ration with ORB Interna tional (Gallup International), 
the European Commission,15 the Philippines Survey and 
Research Center,27 and Wellcome.28 Vaccine confidence 
was measured through three survey statements relating 
to individual perceptions on the impor tance, safety, 
and effec tiveness of vaccines (table). Online, tele phone, 
and face­to­face survey methodologies were used 
(see appendix 1 pp 3–4 for further details on survey 
Research in context
Evidence before this study
We have previously done three systematic reviews identifying 
the key determinants of vaccine hesitancy to inform 
questionnaire design around vaccine confidence. Vaccine 
refusals and delays are contributing to an increasing number 
of vaccine-preventable disease outbreaks (eg, measles and 
polio) globally. For this reason, vaccine hesitancy was named 
by WHO as one of the top ten threats to global health in 2019. 
Factors modulating vaccine confidence and, conversely, 
hesitancy include (but are not limited to) trust in health-care 
systems, providers, governance, information, and perceptions 
of vaccine importance, safety, and efficacy. The Vaccine 
Confidence Project (VCP) was founded 10 years ago to 
establish a systematic approach to monitoring public 
confidence in vaccines. In 2015, the VCP developed the Vaccine 
Confidence Index (VCI) survey: a tool used to monitor 
spatiotemporal trends in vaccine confidence at national and 
global levels.
Added value of this study
We used new and existing VCI surveys comprising nearly 
300 000 individual responses from 149 countries around the 
world, allowing unprecedented insights into global time-
varying trends in vaccine confidence. Datasets previously 
collected in collaboration with ORB International (Gallup 
International), the European Commission, and the Philippines 
Survey and Research Centre were used alongside novel data 
from the Sahel and worldwide data collected up to the end 
of 2019. We used Bayesian tools to estimate national-level 
vaccine confidence trends and to investigate the link in each 
country between vaccine uptake and socioeconomic and 
non-socioeconomic (eg, confidence in vaccine, trust in health 
system) determinants. To our knowledge, this is the largest 
study of global vaccine confidence to date, using a common 
metric to allow cross-country comparisons of vaccine 
sentiment globally.
Implications of all the available evidence
This study provides novel insights into worldwide variations in 
vaccine confidence and presents the country-dependent factors 
that modulate vaccine decisions. These include perceptions of 
vaccine safety, efficacy, and importance; socioeconomic and 
demographic determinants; and individually reported levels of 
trust. The study findings are discussed in light of past and 
ongoing vaccine confidence issues in different settings. A key 
implication of this analysis is the importance of regular 
monitoring of vaccine confidence levels to detect trends and 
changes that suggest the need for interventions to sustain 
confidence and pre-empt negative impacts on vaccination 
uptake.
See Online for appendix 1
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methodologies). Responses to the three statements were 
answered on Likert scales ranging from “strongly dis­
agree” to “strongly agree”. Likert responses presented 
to respondents differed between surveys (appendix 1 p 4); 
however, the outer most categories (“strongly agree” and 
“strongly disagree”) remained consistent across surveys. 
Thus, to allow meaningful comparisons in trends 
between surveys, individual survey responses falling 
between “strongly agree” and “strongly disagree” were 
recoded into the new category “neither strongly agree 
nor strongly disagree”, with the “strongly agree” and 
“strongly disagree” responses remaining unchanged. 
This reclas sification assumes that respondents who 
report the most confident (“strongly agree”) and least 
confident (“strongly disagree”) beliefs are unlikely to 
change their response regardless of whether they are 
presented with additional Likert categories such as “tend 
to agree”, “somewhat agree”, or “neither agree nor 
disagree” (or a combination thereof; appendix 1 p 4).
Of the 290 surveys, 144 were collected as part of the 
2018 Wellcome Global Monitor (WGM; appendix 2).28 In 
addition to probing individuals’ perceptions on vaccine 
confidence across the globe, the WGM also surveys 
individuals on a range of factors including sources of 
trust, information­seeking behaviours, and whether 
respondents with children report having vaccinated 
at least one child against any routine immu nisation 
pro gramme (if the respondent reports having at least 
one child). To explore barriers to vaccine uptake, we 
extracted data from the WGM surveys on demographics 
(sex, age, and religious beliefs) and socioeconomic 
status (income and education, including science edu­
cation), in addition to sources of trust and information­
seeking behaviours. These variables are sum marised in 
the table.
Missing data by country are listed in appendix 1 
(pp 25–26). On average, each survey contained appro­
ximately 1000 individuals. The surveys were weighted 




“I think vaccines are safe” Likert scale recoded to “strongly disagree”, “strongly agree”, 
and “neither strongly agree nor strongly disagree”
Not strongly agree
“I think vaccines are important for children to have” As above As above
“I think vaccines are effective” As above As above
Vaccine uptake†
If respondent has children: “…have any of your children ever 
received a vaccine that was supposed to prevent them from 
getting childhood diseases…?”
Yes, no, do not know; “do not know” responses are recoded to “no” No
Source of trust
“[Who] do you trust most to give you medical or health 
advice?”
Family and friends (social circle), a doctor or nurse, other sources 
(famous people, traditional healers, or none)
A doctor or nurse
“[How much] do you trust medical and health advice from 
the government…?”
A lot, some, not much, not at all; responses are recoded to “high” (a lot) 
and “low” (others)
Low
“[How much] do you trust medical and health advice from 
medical workers, such as doctors and nurses…?”
A lot, some, not much, not at all; responses are recoded to “high” (a lot) 
and “low” (others)
Low




“Have you…tried to get any information about medicine, 
disease, or health in the past 30 days?” and “Would you…
like to know more about medicine, disease, or health?”
A joint information-seeking behaviour variable is defined with 
responses “high” (if “yes” answered to both statements) and “low” 
(otherwise)
Low
Demographics and socioeconomic status
Sex Male or female Female
Age Integer-valued age, scaled to have a mean of 0 and unit SD No baseline
Income quintile Quintiles: Q1 (lowest income) to Q5 (highest income) Q1
Religion: “Could you tell me what your religion is?” For each country, religion is recoded into the most frequently reported 
religion in a given country (largest), all other religious affiliations 
(minority), or refusal to answer (refused)
Other
Education Years in education grouped into <9 years, 9–15 years, and ≥16 years <9 years
Science education: “Have you…learned about science at 
[school]?”
Primary, secondary, university, no, do not know; “primary” and “do not 
know” responses are recoded to “low”, with all others to “high”
Low
*As data on perceptions about the religious compatibility of vaccines was not posed to respondents in the Wellcome Global Monitor, we only consider three statements on 
vaccine confidence. †For this question, vaccine-preventable diseases were given as examples to respondents, which varied by country (see appendix 1 pp 28–29).
Table: Data used throughout the study




See Online for appendix 2
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by sex and age according to national distributions, 
with equal sex representation in most surveys 
(appendix 2).
Model-based estimates of vaccine confidence
The proportion of respondents falling into each of 
the three response categories (“strongly agree”, “strongly 
disagree”, and “neither strongly agree nor strongly 
disagree”) for each confidence statement and in each 
country at any given timepoint was modelled as multi­
nomial logit Gaussian process model.29 Model inference 
was done using Gibbs sampling and 10 000 samples 
(or draws) were obtained from the posterior predictive 
distributions, from which mean estimates were calcu­
lated (see appendix 1 pp 5–7 for full model details). Model 
performance was assessed using out­of­sample validation 
using five­fold cross­validation. Out­of­sample metrics 
indicated good model fit with a mean error of 10−¹⁷, mean 
absolute error of 10·10, and a root mean square error 
of 15·29. Our model was used to estimate vaccine 
confidence across all surveyed countries at two timepoints 
(November, 2015, and November, 2018) when many 
Figure 1: Global trends in perceptions towards the safety of vaccines in November, 2015, and November, 2018
Figure shows model-based estimates of the percentage of respondents strongly agreeing that vaccines are safe (panels A, B), important for children to have (panels C, D), and effective (panels E, F) 
in November, 2015, and November, 2018. No data were available for countries in grey.
A Vaccines are safe B Vaccines are safe
C Vaccines are important D Vaccines are important
E Vaccines are effective F Vaccines are effective
November, 2015
0−29·9 30−39·9 40−49·9 50−59·9 60−69·9 70−79·9 80−89·9 90−99·9
Respondents who strongly agree (%)
November, 2018
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surveys were conducted. To evaluate more recent 
temporal trends, changes in confidence estimates under 
our model are provided between November, 2015, and 
December, 2019. More recent changes in vaccine safety 
perceptions are evaluated for the EU, where a higher 
frequency of surveys has been conducted, on average, 
compared with the rest of the world. A difference of 
posterior distributions of the probability of strongly 
agreeing (and strongly disagreeing) is calculated between 
each country’s two most recent datapoints from 2018 
onwards spaced at least 12 months apart (see appendix 2 
for further details). A change in confidence is recorded if 
Figure 2: Distributions in absolute confidence changes between November, 2015, and December, 2019
Distributions of model-based estimates in the absolute differences in the proportions of respondents strongly agreeing that vaccines are safe, important, and effective. 
Positive values denote an increase in confidence between 2015 and 2019. Owing to increased uncertainty around estimates further away from survey dates, some 
significant changes in confidence over the study period are not captured by this figure.
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the 95% highest posterior density (HPD) interval of 
this difference distribution excludes zero. The same 
methodology is used to identify countries worldwide with 
an increase in the proportions of respondents strongly 
disagreeing that vaccines are safe, important, or effective 
between November, 2015 and December, 2019.
Vaccine uptake determinants
Bayesian logistic regressions were used to investigate 
the link in each country between vaccine uptake 
and confi dence, source of trust, information­seeking 
behavi our, and demographics and socioeconomic 
status (table).30 This analysis serves to highlight 
Figure 3: Trends in the perceived safety of vaccines in the EU and the Philippines
(A) Time series of estimated percentages of respondents in EU countries strongly agreeing, strongly disagreeing, or neither strongly agreeing nor strongly disagreeing that vaccines are safe. Lines are 
means and shaded regions are 95% HPD intervals. Circles show the observed percentage of respondents from raw data (appendix 2). Time series for all countries for all three confidence statements are 
shown in appendix 1 (pp 12–23). (B) Time series of survey responses across all three survey questions for the Philippines. (C) WHO-UNICEF national immunisation estimates for routine vaccination 
programmes in the Philippines against tuberculosis (BCG), diphtheria-pertussis-tetanus (DPT1), measles (MCV1), and polio (Pol3). HPD=highest posterior density.
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consistent trends in uptake determinants across the 
globe and provides a platform for deeper analysis 
examining the most important factors of uptake in 
each country or developing predictive models of 
vaccine uptake.
For the vaccine uptake analysis, we included respon­
dents from the WGM dataset who reported having heard 
of vaccinations and having had children. The strength of 
the relationship between the percentage of respondents 
in each country strongly agreeing that vaccines are impor­
tant, safe, and effective and the percentage of respondents 
reporting having had their children vaccinated was 
assessed using Pearson’s correlation coef cient, where 
percentages p were first transformed onto the real line 
using −log(100/p – 1).
All models were implemented in JAGS31 using R 
(version 3.6.1). 95% HPD inter vals were used to represent 
confidence in parameter esti mates. The 95% HPD interval 
is the smallest interval of the posterior distribution that 
contains 95% of the proba bility mass. Raw survey data 
for all 290 sur veys can be found in appendix 2, along­
side model­based vaccine confidence estimates from 
November, 2015, to January, 2020.
Role of the funding source
The funders of the study had no role in study design, 
data collection, data analysis, data interpretation, or 
writing of the report. The corresponding author had 
full access to all the data in the study and had final 
responsibility for the decision to submit for publication.
Results
Model­based estimates of the percentage of respondents 
strongly agreeing that vaccines are safe, important, and 
effective in 2015 and 2018 are shown in figure 1. Estimates 
for all countries with associated uncertainties are shown 
in the appendices, alongside time­series plots showing 
temporal trends in vaccine confidence (appendix 1 
pp 8–23; appendix 2).
Argentina (89·4%, 95% HPD interval 87·7–91·3), Liberia 
(86·1%, 67·1–97·7), and Bangladesh (86·1%, 83·7–88·1) 
had the highest estimated percentage of respondents 
strongly agreeing that vaccines are safe in late 2015, 
whereas Japan (8·9%, 7·4–10·6), France (8·9%, 7·2–10·5), 
and Mongolia (8·1%, 6·4–9·8) had the lowest (figure 1A).
Ethiopia (96·3%, 95% HPD interval 95·2–97·3), 
Argentina (95·7%, 94·5–97·0), and Bangladesh (95·1%, 
93·8–96·4) had the highest estimated percentage of 
respondents strongly agreeing that vaccines are impor­
tant in 2015, whereas Turkey (22·1%, 19·5–24·7), Morocco 
(15·8%, 13·7–18·4), and Georgia (2·7%, 1·6–3·8) had the 
lowest (figure 1C).
Ethiopia (86·6%, 84·5–88·7), Argentina (86·3%, 
84·3–88·4), and Mauritania (81·9%, 64·4–97·2) had the 
highest estimated percentage of respondents strongly 
agreeing that vaccines are effective in late 2015, whereas 
Japan (14·7%, 12·5–16·7), Mongolia (13·0%, 11·0–15·2), 
and Morocco (10·3%, 8·6–12·2) had the lowest (figure 1E).
Between November, 2015, and December, 2019, we 
estimate that vaccine confidence fell for all three elements 
Figure 4: Univariate determinants of vaccine uptake within the Wellcome Global Monitor dataset 
Global trends in univariate associations between vaccine uptake and confidence in vaccines, demographics 
and socioeconomic status, sources of trust, and information-seeking behaviours. Each point represents a 
significant association (95% HPD interval excludes zero) between a variable and uptake in a given country. 
Boxplots show the median log risk ratio and IQR. All variables (except age, which is continuous) are categorical 
and baseline groups are specified by each category (eg, high vs low denotes low as the baseline group; see the 
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of confidence in Indonesia, the Philippines, Pakistan, and 
South Korea, and for two elements in Afghanistan and 
Vietnam (figure 2). The Philippines, which ranked in 
the top ten countries worldwide in late 2015 for vaccine 
confidence for all three elements, ranked no higher 
than 70th in 2019, having experienced a large fall in 
the percentage of respondents strongly agreeing that 
vaccines are safe (absolute difference 23·1%, 95% HPD 
interval 6·3–40·0), important (23·0%, 7·4–37·4), and 
effective (23·7%, 8·5–39·7; figure 2). Indonesia also 
witnessed large drops in confidence over this time in all 
three elements: vaccine safety (absolute difference 13·8%, 
9·0–18·9), importance (14·6%, 9·9–19·5), and effective­
ness (12·2%, 7·5–17·7; figure 2). Vaccine confidence 
increased between 2015 and 2019 across all three elements 
for France, India, Mexico, Poland, Romania, and Thailand 
(figure 2).
Time­series trends in vaccine confidence until the end 
of 2019 are shown for the EU (including the UK) and the 
Philippines (figure 3). Recent losses in the percentage of 
respondents agreeing that vaccines are safe (between 
2018 and late 2019) are detected in Poland, with increases 
detected in Finland, France, Ireland, Italy, and the UK 
(figure 3A; appendix 2). Vaccine confidence plummeted 
between 2015 to 2018 in the Philippines (over well 
documented fears around the Dengvaxia vaccine 
in 201727,32,33); however, since the start of 2018, confidence 
in the importance of vaccines has made substantial 
gains, with less substantial increases in vaccine safety 
and effectiveness perceptions (figure 3B). The loss of 
vaccine confidence in the Philippines triggered by fears 
over Dengvaxia appears to also have affected uptake of 
routine vaccines recom mended by the national immuni­
sation programme (figure 3C).27 This pattern is not 
limited to the Philippines: there were larger increases in 
the percentage of respondents perceiving vaccines to be 
important than safe or effective across the majority of 
countries in the European region for which there was 
an improvement in recorded importance confidence 
(figure 2).
For ten countries worldwide, our model estimated 
a higher percentage of respondents strongly disagree­
ing that vaccines are safe, important, or effective 
in December, 2019, compared with November, 2015 
(appendix 1 p 24): Afghanistan, Azerbaijan, Bosnia 
and Herzegovina, Georgia, Indonesia, Japan, Malaysia, 
Nigeria, Pakistan, and Serbia. Of note, Afghanistan, 
Azerbaijan, Indonesia, Nigeria, Pakistan, and Serbia 
all had increased concerns about vaccine safety 
(appendix 1 p 24)
Significant associations between uptake and vaccine 
confidence, sources of trust, information­seeking behav­
iour, and demographics and socioeconomic status are 
shown in figure 4, with consistent trends shown across 
the globe. Overall, the deter minants most consistently 
associated with improved uptake were high confidence 
in vaccines (66 countries); trusting health­care workers 
more than family, friends, or other non­medical sources 
for medical and health advice (43 countries); higher 
levels of science education (35 countries); sex, with 
women more likely than men to report any child having 
at least one vaccine in 41 countries and men more likely 
than women in just one country (Chad); age (younger 
age groups associated with increased chances of uptake 
in 43 countries); and high information­seeking behaviour 
(18 countries). Income and religion were less widely 
associated with uptake; however, when a link was found 
between religion and uptake, it is the minority religious 
groups (or those refusing to provide their religious 
belief) who were associated with lower probability of 
uptake (figure 4).
Countries with higher percentages of respondents 
strongly agreeing that vaccines are safe, important, 
and effective had higher percentages of respondents 
reporting that they have had their children vaccinated 
(WGM data only; figure 5). These effect sizes are small 
Figure 5: Association between national level vaccine uptake and vaccine confidence as reported in the Wellcome Global Monitor
The solid line represents the mean regression with 70% and 95% HPD intervals shaded in dark and light grey, respectively. Datapoints for (lowest confidence) and the 
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but significant, with a Pearson’s correlation of 0·28 
(95% CI 0·12–0·42) between the percentage strongly 
agreeing that vaccines are safe and the percentage of 
respondents reporting vaccinating their children across 
all countries, 0·45 (0·31–0·57) for vaccine importance 
and uptake, and 0·28 (0·12–0·42) for vaccine effective­
ness and uptake.
Discussion
To our knowledge, this is the largest study of vaccine 
confidence, offering important insights into the global 
state of vaccine confidence. Vaccine confidence was esti­
mated and mapped for 149 countries from 2015 to 2019, 
revealing key spatial and temporal trends. Although 
confidence remained low across Europe compared with 
other continents, there are signs that vaccine confidence 
is increasing for much of Europe, including France, where 
vaccine confidence has been persistently low since 2015. 
Confidence increased overall in Poland between 2015 and 
2019, but a recent loss in confidence was seen between 
late 2018 and late 2019, reflecting the growing impact of 
a highly organised local anti­vaccine movement.34
Between 2015 and 2018, vaccine confidence plum­
meted in the Philippines and Indonesia. In 2017, the 
vaccine manu facturer Sanofi announced that their newly 
introduced dengue vaccine Dengvaxia posed a risk to 
individuals who had not previously been exposed to the 
virus, prompting outrage and panic across the population 
where nearly 850 000 children had been given the new 
vaccine the previous year. As the VCP measured a 
baseline confidence value in 2015, we were able to 
measure the change in confidence following the vaccine 
scare and found a significant drop in confidence in 
vaccine importance, safety, effectiveness.27 The VCI 
survey tool has detected a rise in confidence across 
the country—although con fidence is not back to 2015 
levels—indicating a possible recovery and highlighting 
the value of the tool in assessing the effectiveness of 
national­level policy.
Japan ranked among the countries with the lowest 
vaccine confidence in the world: this might be linked to the 
human papillomavirus (HPV) vaccine safety scares that 
started in 2013, and following the decision by the Japanese 
Ministry of Health, Labour and Welfare in June, 2013, to 
suspend proactive recommendation of the HPV vaccine.35 
As a result of this vaccine safety scare, HPV vaccination 
coverage decreased from 68·4–74·0% in the 1994–98 birth 
cohort to 0·6% in the 2000 birth cohort.36 The news of 
Japan suspending their proactive recommendation of the 
HPV vaccine has travelled globally through online media 
and social media networks, being applauded by anti­
vaccination groups but not by the global scientific 
community.4 The way in which the HPV vaccine scare was 
approached by health ofcials, as well as an ongoing 
outbreak of rubella in Japan,37,38 indicate continuing issues 
with the Japanese vaccination pro gramme that need 
resolving.39
Indonesia witnessed a large drop in confidence 
between 2015 and 2019, partly triggered by Muslim 
leaders questioning the safety of the measles, mumps, 
and rubella (MMR) vaccine, and ultimately issuing a 
fatwa—a religious ruling—claiming that the vaccine was 
haram and contained ingredients derived from pigs and 
thus not acceptable for Muslims. Local healers promoting 
natural alternatives to vaccines also contributed to the 
waning confidence in vaccines.40,41
Results from our survey can inform the need for 
further research, to explore why certain countries might 
expe rience sudden increases or decreases in confidence. 
We have highlighted countries with marked decreases 
in percentages reporting that they strongly agree that 
vaccines are safe and countries with significant increases 
in those strongly disagreeing that vaccines are safe. These 
countries are candidates for more nuanced follow­up 
surveys to understand the precise drivers of confidence 
and the link between confidence and uptake.
In South Korea and Malaysia, online mobilisation 
against vaccines has been identified as a key barrier to 
vaccination.42,43 The internet is a main source of vacci­
nation information in Malaysia, where misinformation 
has been identified as influencing vaccine reluctance.44 
In South Korea, an online community named ANAKI 
(Korean abbreviation of “raising children without medi­
cation”) has been strongly advocating against childhood 
immunisation.45 Future studies in both countries should 
further investigate this trend and propose mitigation 
strategies. In Georgia, unfounded vaccine safety concerns, 
amplified by the media, were found to profoundly affect 
a nationwide MMR vaccine campaign in 2008.46 Our 
findings of low vaccine confidence in Georgia could 
suggest that concerns about vaccine safety are again on 
the rise.
The determinants of vaccine uptake across the globe 
show strong consistency, with being male or having 
fewer years of education associated with decreased 
chances of uptake. Positive information­seeking behav­
iours and trusting health­care workers more than other 
sources such as one’s social circle for medical and health 
advice were associated with increased chances of uptake.
There are several study limitations to note. First, as not 
all surveys used have consistent responses, we have 
made a key assumption that, presented with different 
options between the extreme categories of “strongly 
agree” and “strongly disagree” (which are consistent 
across all surveys), respondents with the strongest 
sentiment will fall into one of these extreme groups 
regardless of additional categories. While this approach 
probably allows meaningful comparison across sur­
veys—although it needs testing for validation—it pools 
vacci nation beliefs among those without the strongest 
beliefs, masking potentially key information. Second, the 
WGM survey data only permit an investigation of uptake 
defined as whether a parent has had any of their children 
vaccinated against at least one childhood disease. These 
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uptake data are therefore not defined on a vaccine or 
child­by­child basis, precluding an investigation of 
determinants of vaccine­specific or child­specific uptake 
(which has been done recently in the literature22,24,41). 
Moreover, we rely on parental recall being accurate, and 
patterns of recall error not varying substantially across 
countries. Finally, owing to low case counts of respon­
dents who have not had their children vaccinated 
(appendix 2) and the varying religious groups across 
countries, religious groups were recoded into the largest 
and minority groups to extract results from our regres­
sion analysis. In many settings, more nuanced regression 
findings are possible, and a compre hensive regression 
analysis could reveal more informative country­specific 
determinants of vaccine uptake.
Sentiments seeding doubt and distrust and the viral 
spread of misinformation are contributing to a landscape 
of uncertainty. Some actors have purposefully polarised 
vaccine debates, exploiting the doubting public and 
system weaknesses for political purposes,47,48 while 
waning vaccine confidence in other settings might be 
influenced by a wider environment of distrust in govern­
ment and scientific elites.14 The findings of declining 
confidence in Afghanistan, Azerbaijan, Pakistan, and 
Nigeria mirror trends in political instability and religious 
extremism in these settings.49 Over the past few years in 
Pakistan and Nigeria, new waves of misinformation 
surrounding the polio vaccine have been circulating,50,51 
and have led to recent increases in poliovirus cases in 
both countries.52 Further research should investigate the 
link between political polarisation, religious extremism, 
and populism and vaccination beliefs to better under­
stand these complex ties.48 Having a common metric of 
confidence and a baseline for comparison is crucial to 
understanding these changing trends over time, which 
can serve as an early warning system to prompt needed 
intervention to avert drops in vaccine confidence and 
acceptance.
In the context of new and emerging disease outbreaks, 
such as the COVID­19 pandemic, the VCI provides a 
valuable baseline of confidence levels to measure change 
in times of evolving disease threats and to help to identify 
where more trust building is needed to optimise uptake 
of new life­saving vaccines.
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